A

Alector (ALEC)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Alector (ALEC)

Alector, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration. Immuno-neurology targets immune dysfunction as a cause of multiple pathologi... Read more

  • USD6.15
  • USD6.43
  • USD6.11
  • USD15.39
  • -29.50%
  • 134M
  • 340.20k
  • 615.25k
  • 513M
  • 5.76
  • -59.30%

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.